TRPM2-AS Promotes Paclitaxel Resistance in Prostate Cancer by Regulating FOXK1 via Sponging miR-497-5p

Transient receptor potential cation channel subfamily M member 2 antisense RNA (TRPM2-AS) knockdown suppressed cell progression and paclitaxel (PTX) resistance in PTX-resistant prostate cancer cells by miR-497-5p/FOXK1 axis.